Lataa…
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
SIMPLE SUMMARY: Immune checkpoint inhibitors have been shown to improve survival in patients with advanced melanoma; however, a proportion of patients do not experience durable clinical benefit with these agents. Findings from a previous study suggested that the use of proton pump inhibitors while r...
Päätekijät: | , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Online Artikkeli Teksti |
Kieli: | English |
Julkaistu: |
MDPI
2022
|
Aiheet: | |
Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103038/ https://www.ncbi.nlm.nih.gov/pubmed/35565428 http://dx.doi.org/10.3390/cancers14092300 |